PA ANALYSIS: Could AstraZeneca be the next big takeover target?
Witnessing AstraZeneca’s share price dive Thursday morning has given some investors a sense of déjà vu and sparked ideas that Britain’s second largest pharma firm could be vulnerable to another takeover bid.